Acotec Scientific Holdings Limited announced that on January 30, 2024, the Company received the registration approval from the PRC National Medical Products Administration for the Peridge ®, a Peripheral Scoring Balloon Dilatation Catheter, which is used for the treatment of stenotic lesions in autologous or synthetic arteriovenous fistulae for hemodialysis. Peridge ® provides effective anchoring points and aids in the directed opening of lesions, reducing the incidence and severity of elastic recoil for plaques or proliferative intimal tissue and flow-limiting dissections while dilating the vessel lumen, thereby minimizing excessive vascular injury. This product can facilitate better vessel preparation for drug-coated balloons (DCB) treatment.

The Company will carry out marketing activities in PRC market when appropriate.